News

Article

AJMC® in the Press, March 1, 2024

Author(s):

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article on mHealthIntelligence referenced a study published in the February 2024 issue of The American Journal of Managed Care® (AJMC®). The study, “Scaling Care Coordination Through Digital Engagement: Stepped-Wedge Trial Assessing Readmissions,” found that a patient postdischarge digital engagement program was able to offer patients in resource-limited areas expanded access to care while also having no effect on readmissions.

An article from POZ referenced an article published on AJMC.com, the website of AJMC. The article, “Vaccination for Hepatitis A Low in People Living With HIV,” summarized a study that found that lower hepatitis A virus vaccination uptake was common in patients with substance use disorders, young patients, and patients who were immunocompromised if they had HIV.

An article from BNN Breaking referenced an article published on AJMC.com. The article, “Not So Rare: 300 Million People Worldwide Affected by Rare Diseases,” discussed new research that found about 4% of the total population of the world were affected by a rare disease of some kind.

The written interview titled, “Dr Leesha Ellis-Cox Confronts Racial Bias, Diagnosis Disparities in Mental Health Care,” was referenced in Nation World News. The written interview featured questions answered by Ellis-Cox on reasons for less mental health diagnoses in Black Americans and why underrepresentation of Black Americans in the health care system poses a challenge to other Black Americans with a mental health diagnosis.

Related Videos
Fulling and Cournoyer
Crystal S. Denlinger, MD, FACP, CEO of the National Comprehensive Cancer Network
Tiara Green, MSEd
Panagis Galiatsatos, MD, MHS, an expert on bronchiectasis
Panagis Galiatsatos, MD, MHS, an expert on bronchiectasis
Jason Porter, MD, an expert on lung cancer
Jason Porter, MD, an expert on lung cancer
Joseph Mikhael, MD, an expert on multiple myeloma
A panel of 3 experts on multiple sclerosis
A panel of 3 experts on multiple sclerosis
Related Content
CH LogoCenter for Biosimilars Logo